All In Biotech

Drug Trial Radar · NCT05686642

Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

A Phase II Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Study to Evaluate the Safety and Efficacy of LT3001 in Subjects With Acute Ischemic Stroke (AIS)

Last checked: Nov 19, 2026Latest source record: Apr 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Apr 6, 2023

Primary completion

Dec 10, 2026

Study completion Dec 12, 2026

Sponsor

Sponsor type
Industry
First posted
Jan 17, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase II clinical study is designed to evaluate the safety and efficacy of LT3001 in the treatment of acute ischemic stroke

Conditions

  • Acute Ischemic Stroke

Interventions

  • LT3001 Drug:high doseDrug

    Administered by intravenous infusion.

  • PlaceboDrug

    Administered by intravenous infusion.

  • LT3001 Drug:low doseDrug

    Administered by intravenous infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence Adverse EventsTime frame: Approximately 2 years

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Tiantan Hospital, Capital Medical University

    Beijing, China · Recruiting

  • Beijing Tsinghua Changgung Hospital

    Beijing, China · Recruiting

  • Linfen Central Hospital

    Linfen, China · Recruiting

  • Linfen People's Hospital

    Linfen, China · Recruiting

  • Nanshi Hospital of Nanyang

    Nanyang, China · Recruiting

  • Shanghai Pudong Hospital

    Shanghai, China · Recruiting

  • Central People's Hospital of Zhanjiang

    Zhanjiang, China · Recruiting

  • Beijing Luhe Hospital Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital of Jinan University

    Guangzhou, Guangdong, China · Recruiting

  • Luoyang Third People's Hospital

    Luoyang, He'nan, China · Recruiting

  • Harrison International Peace Hospital

    Hengshui, Hebei, China · Recruiting

  • Daqing Oilfield General Hospital

    Daqing, Heilongjiang, China · Recruiting

  • Zhongnan Hospital of Wuhan University

    Wuhan, Hubei, China · Recruiting

  • The First Affiliated Hospital of Baotou Medical College

    Baotou, Inner Mongolia, China · Recruiting

  • Inner Mongolia Baogang Hospital

    Baotou, Inner Mongolia, China · Recruiting

  • Huai'an Second People's Hospital

    Huai'an, Jiangsu, China · Recruiting

  • The Second Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, China · Recruiting

  • The Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, China · Recruiting

  • Pingxiang People's Hospital

    Pingxiang, Jiangxi, China · Recruiting

  • The First Bethune Hospital of Jilin University

    Changchun, Jilin, China · Recruiting

  • Beipiao Central Hospital

    Chaoyang, Liaoning, China · Recruiting

  • Liaocheng People's Hospital

    Liaocheng, Shandong, China · Recruiting

  • Xi'an Gaoxin Hospital

    Xi’an, Shanxi, China · Recruiting

  • Yan'an University Xianyang Hospital

    Xianyang, Shanxi, China · Recruiting

  • The Third Hospital of Mianyang

    Mianyang, Sichuan, China · Recruiting

  • Zhejiang Hospital

    Hangzhou, Zhejiang, China · Recruiting

  • Taizhou Municipal Hospital

    Taizhou, Zhejiang, China · Recruiting

  • Taizhou First People's Hospital

    Taizhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.